• LAST PRICE
    21.2400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    21.2300/ 1
  • Ask / Lots
    21.3800/ 1
  • Open / Previous Close
    21.3100 / 21.2400
  • Day Range
    Low 21.2150
    High 21.3200
  • 52 Week Range
    Low 2.3100
    High 21.5500
  • Volume
    400,034
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 21.26
TimeVolumeFUSN
09:32 ET485621.3
09:34 ET81421.32
09:39 ET60021.29
09:43 ET10021.28
09:45 ET51821.28
09:50 ET20021.27
09:52 ET30421.2702
09:56 ET85121.28
09:57 ET70721.27
09:59 ET10021.27
10:01 ET20021.26
10:03 ET215221.28
10:06 ET30021.2718
10:08 ET80021.27
10:12 ET150021.25
10:14 ET1054921.26
10:15 ET329021.25
10:19 ET40021.24
10:24 ET10021.24
10:26 ET30021.24
10:28 ET983921.23
10:30 ET10021.22
10:32 ET405921.23
10:33 ET9351521.226
10:37 ET80021.22
10:42 ET259621.22
10:44 ET160021.22
10:46 ET100021.22
10:48 ET30021.22
10:50 ET724021.24
10:51 ET28421.24
10:53 ET40021.245
10:55 ET60021.25
10:57 ET90121.2326
11:02 ET10021.24
11:04 ET50021.23
11:06 ET50021.236
11:08 ET125821.24
11:09 ET961421.26
11:11 ET200421.28
11:13 ET10021.28
11:15 ET43721.29
11:18 ET20021.29
11:20 ET40021.285
11:24 ET40021.29
11:26 ET30021.28
11:27 ET98021.26
11:29 ET15021.27
11:31 ET10021.26
11:36 ET40021.26
11:38 ET10021.27
11:44 ET57321.27
11:49 ET20021.255
11:51 ET10021.26
11:54 ET40021.25
11:56 ET10021.26
11:58 ET20021.26
12:00 ET10021.26
12:05 ET50021.2522
12:07 ET297721.24
12:09 ET107121.25
12:12 ET10021.27
12:14 ET10021.27
12:18 ET10021.27
12:21 ET20021.2601
12:23 ET10021.26
12:25 ET40021.26
12:27 ET70021.25
12:30 ET20021.25
12:32 ET20021.25
12:34 ET25021.26
12:36 ET163521.25
12:38 ET30021.24
12:41 ET10021.24
12:43 ET486621.25
12:50 ET10021.24
12:52 ET90021.25
12:54 ET222321.25
12:56 ET22121.2507
01:03 ET10021.26
01:06 ET60021.25
01:08 ET70021.245
01:19 ET59021.245
01:24 ET10021.245
01:26 ET110021.25
01:28 ET70821.25
01:32 ET560021.25
01:33 ET100021.26
01:35 ET120021.2503
01:37 ET20021.26
01:42 ET13021.255
01:44 ET40021.26
01:46 ET80021.25
01:51 ET20021.255
01:53 ET204921.2483
01:55 ET63721.2402
01:57 ET255121.24
02:02 ET41321.27
02:04 ET70021.255
02:06 ET30021.26
02:11 ET30021.26
02:13 ET50021.25
02:15 ET10021.25
02:20 ET10021.24
02:24 ET10021.24
02:26 ET10021.25
02:27 ET70021.2499
02:29 ET10021.24
02:31 ET71021.2407
02:33 ET70021.245
02:36 ET20021.24
02:40 ET10021.245
02:44 ET394721.25
02:47 ET744721.26
02:51 ET64321.25
02:54 ET148621.245
02:56 ET216321.24
02:58 ET20021.24
03:02 ET10021.245
03:03 ET80021.25
03:07 ET90021.245
03:09 ET28821.245
03:12 ET10021.24
03:16 ET62421.24
03:18 ET728321.245
03:20 ET10021.24
03:23 ET20021.24
03:25 ET10021.245
03:27 ET33221.245
03:30 ET20021.24
03:32 ET40021.245
03:34 ET130921.245
03:36 ET30021.245
03:38 ET10021.24
03:39 ET97421.24
03:41 ET163021.24
03:45 ET200621.24
03:48 ET50021.24
03:50 ET99021.24
03:52 ET1330921.25
03:54 ET4584321.24
03:56 ET356521.24
03:57 ET876221.24
03:59 ET3455321.24
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFUSN
Fusion Pharmaceuticals Inc
1.8B
-14.5x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
1.8B
-7.0x
---
United StatesGPCR
Structure Therapeutics Inc
1.8B
-14.8x
---
United StatesSANA
Sana Biotechnology Inc
1.8B
-5.6x
---
United StatesNMRA
Neumora Therapeutics Inc
1.7B
-4.5x
---
United StatesINBX
Inhibrx Inc
1.6B
-6.9x
---
As of 2024-04-18

Company Information

Fusion Pharmaceuticals Inc. is a clinical-stage oncology company. The Company is focused on developing radiopharmaceuticals as precision medicines. It has developed its Targeted Alpha Therapies (TAT), platform to enable it to connect alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha particle payloads to tumors. The TAT platform is underpinned by its ability to radiolabel various classes of targeting molecules, its research and insights into the underlying chemistry and biology of alpha emitting radiopharmaceuticals, its differentiated capabilities in target identification, candidate generation, manufacturing and supply chain, its Fast-Clear linker technology used in conjunction with antibody-based targeting molecules, and development of imaging agents. Its clinical portfolio includes FPI-2265, FPI-1434 and FPI-2059. FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer in a Phase 2 trial.

Contact Information

Headquarters
270 Longwood Rd. SHAMILTON, ON, Canada L8P 0A6
Phone
289-799-0891
Fax
---

Executives

Independent Chairman of the Board
Barbara Duncan
President, Chief Business Officer
Mohit Rawat
Chief Executive Officer, Founder, Director
John Valliant
Chief Financial Officer
John Crowley
Chief Technology Officer
Eric Burak

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.8B
Revenue (TTM)
$2.1M
Shares Outstanding
84.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.69
EPS
$-1.47
Book Value
$2.79
P/E Ratio
-14.5x
Price/Sales (TTM)
870.7
Price/Cash Flow (TTM)
---
Operating Margin
-4,798.45%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.